RxDoctor Payments Data

Alison Pietras

Medical · Brick, NJNPI 1669961629

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Eisai Inc. accounts for 97.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2023 at $4,365 and has fallen 99.6% since, to $18 in 2025. Among medical clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,381in general payments, 2019–2025

Across 17 payments — averaging $375.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$6K
  • Lilly USA, LLC$125
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$18
$1,232,878in research payments, 2019–2025

Across 2 payments — averaging $616,439 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$1.2M

What the payments were for

  • Consulting fees$1,73527%
  • Speaking & faculty fees$3,28051%
  • Travel & lodging$85913%
  • Food & beverage$5088%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,381 in reported general payments places this provider in the 90th percentile of 573 medical providers in New Jersey.

See all medical providers in New Jersey

Medicare billing

Part B allowed, 2024
$84,618
Medicare patients
329
Services billed
581

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Rivastigmine87$14,310
Memantine Hcl ErMemantine Hcl122$12,711
Memantine Hcl214$10,726
Donepezil Hcl435$5,604
Galantamine ErGalantamine Hbr65$4,642
Divalproex Sodium50$3,125
RivastigmineRivastigmine Tartrate42$2,914
Escitalopram Oxalate240$2,511
Risperidone OdtRisperidone13$2,074
Mirtazapine53$1,452
Quetiapine Fumarate117$1,400
Galantamine Hbr16$992
Trazodone Hcl85$771
Duloxetine Hcl21$766
Levetiracetam12$532

Paid to pharmacies, not to this prescriber.

Other medical in Brick

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →